These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 16020744

  • 1. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.
    Civeira F, Castillo S, Alonso R, Meriño-Ibarra E, Cenarro A, Artied M, Martín-Fuentes P, Ros E, Pocoví M, Mata P, Spanish Familial Hypercholesterolemia Group.
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1960-5. PubMed ID: 16020744
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.
    Mozas P, Castillo S, Reyes G, Tejedor D, Civeira F, García-Alvarez I, Puzo J, Cenarro A, Alonso R, Mata P, Pocoví M, Spanish group FH.
    Am Heart J; 2003 Jun; 145(6):999-1005. PubMed ID: 12796755
    [Abstract] [Full Text] [Related]

  • 3. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
    Vergopoulos A, Bajari T, Jouma M, Knoblauch H, Aydin A, Bähring S, Mueller-Myhsok B, Dresel A, Joubran R, Luft FC, Schuster H.
    Eur J Hum Genet; 1997 Oct 16; 5(5):315-23. PubMed ID: 9412789
    [Abstract] [Full Text] [Related]

  • 8. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT, Chaves FJ, Martínez-Usó I, García-García AB, Ascaso JF, Carmena R.
    Eur Heart J; 2001 Mar 16; 22(6):465-71. PubMed ID: 11237541
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the CXCL3 gene in response to oxidized low-density lipoprotein is associated with the presence of tendon xanthomas in familial hypercholesterolemia.
    Martín-Fuentes P, Civeira F, Solanas-Barca M, García-Otín AL, Jarauta E, Cenarro A.
    Biochem Cell Biol; 2009 Jun 16; 87(3):493-8. PubMed ID: 19448742
    [Abstract] [Full Text] [Related]

  • 10. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy.
    Clemens P, Beisiegel U, Steinhagen-Thiessen E.
    Helv Paediatr Acta; 1986 Aug 16; 41(3):173-82. PubMed ID: 2944857
    [Abstract] [Full Text] [Related]

  • 11. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G, Cariolou MA, Elisaf M.
    Ann Clin Lab Sci; 2002 Aug 16; 32(1):50-4. PubMed ID: 11848618
    [Abstract] [Full Text] [Related]

  • 12. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia.
    Kolovou GD, Anagnostopoulou KK, Pilatis ND, Giannopoulou M, Hoursalas IS, Pavlidis AN, Adamopoulou E, Valaora AI, Mikhailidis DP, Cokkinos DV.
    J Womens Health (Larchmt); 2004 Dec 16; 13(10):1119-26. PubMed ID: 15650345
    [Abstract] [Full Text] [Related]

  • 13. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL, Van Acker P, Tan H, Deslypere JP.
    Med J Malaysia; 2000 Dec 16; 55(4):409-18. PubMed ID: 11221151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway.
    Oosterveer DM, Versmissen J, Yazdanpanah M, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Eur Heart J; 2010 Apr 16; 31(8):1007-12. PubMed ID: 20019024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP, Ghani R, Ahmed KZ, Yaqoob Z.
    J Coll Physicians Surg Pak; 2011 Jul 16; 21(7):403-6. PubMed ID: 21777527
    [Abstract] [Full Text] [Related]

  • 19. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC, Pricker KL, Hayden MR, van der Ende BE, Kastelein JJ.
    Arch Intern Med; 1993 Oct 25; 153(20):2349-56. PubMed ID: 8215738
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
    Schmidt HH, Tietge UJ, Buettner J, Barg-Hock H, Offner G, Schweitzer S, Dedoussis GV, Rodeck B, Kallfelz HC, Schlitt HJ, Oldhafer K, Klempnauer J.
    Clin Transplant; 2008 Oct 25; 22(2):180-4. PubMed ID: 18339137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.